PRF1 and cancer: Natural killer cells are emerging as immunotherapy candidates in cancer due to their rapid and efficient immunosurveillance and mobilization to destroy tumour cells,6, 28 in which the cytolytic activity of NK cells can be exerted by expression of perforin and granzymes.29